Answers are grounded in this paper and cite their sources.
Exercise may influence Alzheimer’s disease (AD) through metabolic, redox, and inflammatory pathways that intersect with ferroptosis, but the causal meaning of individual marker changes depends on experimental design. This structured critical evidence reappraisal examined the causal depth supported by AD-specific exercise studies meeting operational ferroptosis-relevant endpoint criteria. PubMed, Web of Science Core Collection, and Scopus were searched through 31 July 2026, with mechanistic bridge searches, a targeted update on 5 October, and PubMed currency checks through 31 October 2026. Three AD exercise studies were re-extracted at the outcome level and evaluated with an author-developed, non-preregistered, retrospectively applied four-level framework intended for external evaluation. Belaya et al. and Li et al. support Level 1. Choi et al. provisionally supports marker-based Level 2 because reported exercise-related differences span iron and lipid/antioxidant domains; however, the published assay size of n = 6/group is difficult to reconcile with F(3,23), tempering confidence in that assignment. Marker-based Level 2 indicates a vulnerability-consistent metabolic profile rather than functional confirmation of altered susceptibility. Overall, current AD exercise evidence remains concentrated at Levels 1–2, while ferroptotic execution and exercise-specific mediation require direct cell-death attribution, dependency/rescue testing, temporal ordering, and factorial exercise-by-perturbation designs. The eligible corpus was animal-based, underscoring the need for human biomarker studies linked to central AD-relevant measures.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: